Acute lymphoblastic leukaemia: open trials in Israel

13 open trials have a site in Israel. Registry data; only the trial team decides who can take part.

NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Rambam Health Care Campus-Pediatric Hemato-Oncology (Site 1674), Haifa · Sheba Medical Center (Site 1675), Ramat Gan
Registry updated 2026-10-30
NCT07570173
A Clinical Trial of MK-1045 in People With B-cell Acute Lymphoblastic Leukemia (MK-1045-005)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
Rambam Health Care Campus (Site 0903), Haifa · Haddasah Medical Center (Site 0900), Jerusalem · Sheba Medical Center (Site 0902), Ramat Gan · Sourasky Medical Center. (Site 0904), Tel Aviv
Registry updated 2026-10-30
NCT07476729
International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)
Trial Treatment · Phase 3 · Charite University, Berlin, Germany
Tel Aviv Sourasky Medical Centre Dana-Dwek Children's Hospital, Tel Aviv
Registry updated 2026-10-26
NCT05327894
Interfant-21 Treatment Protocol for Infants Under 1 Year With KMT2A-rearranged ALL or Mixed Phenotype Acute Leukemia
Trial Treatment · Phase 3 · Princess Maxima Center for Pediatric Oncology
Schneider Childrens Medical Center, Petah Tikva
Registry updated 2026-10-19
NCT07387926
Safety and Efficacy of Asciminib in Pediatrics and Young Adults With Relapse/Refractory (r/r) Philadelphia Positive (Ph+) or ABL-class Ph-like Acute Lymphoblastic Leukemia (ALL)
Trial Treatment · Phase 1/2 · Novartis Pharmaceuticals
Ramat Gan
Registry updated 2026-10-15
NCT04065399
A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation
Trial Treatment · Phase 1/2 · Syndax Pharmaceuticals
Rambam Health Care Campus (RHCC), Haifa · Shaare Zedek Medical Center, Jerusalem · Hadassah Medical Center - Ein Kerem, Jerusalem · Galilee Medical Center, Nahariya · Rabin Medical Center, Petah Tikva · Sheba medical center, Ramat Gan
Registry updated 2026-10-09
NCT05748171
A Study to Learn More About the Study Medicine Called Inotuzumab Ozogamicin (InO) in Children (1 to <18 Years) With First Relapse ALL
Trial Treatment · Phase 2 · Pfizer
Rambam Health Care Campus, Haifa · Schneider Children's Medical Center, Petah Tikva · The Edmond and Lily Safra Children's Hospital; The Chaim Sheba Medical Center, Ramat Gan · Tel-Aviv Sourasky Medical Center Dana-Dwek Children's Hospital, Tel Aviv
Registry updated 2026-09-24
NCT01949129
Allogeneic Stem Cell Transplantation for Children and Adolescents With Acute Lymphoblastic Leukaemia
Trial Treatment · Phase 2/3 · St. Anna Kinderkrebsforschung
Rambam Medical Center, Haifa · Schneider Children's Medical Center of Israel, Petah Tikva · Dana Children's Hospital, Tel Aviv
Registry updated 2026-09-04
NCT03590171
International Study for Treatment of High Risk Childhood Relapsed ALL 2010
Trial Treatment · Phase 2 · Charite University, Berlin, Germany
Tel Aviv Sourasky Medical Centre, Tel Aviv
Registry updated 2026-03-17
NCT05658640
HEM iSMART-D: Trametinib + Dexamethasone + Chemotherapy in Children With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Schneider's Children's Medical Center, Petah Tikva · Sheba Medical Center Hospital, Ramat Gan
Registry updated 2025-09-16
NCT05745714
HEM-iSMART-C: Ruxolitinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Schneider's Children's Medical Center, Petah Tikva · Sheba Medical Center Hospital, Ramat Gan
Registry updated 2025-09-16
NCT05751044
HEM-iSMART-B: Dasatinib + Venetoclax + Dexamethasone + Cyclophosphamide and Cytarabine in Pediatric Patients With Relapsed or Refractory Hematological Malignancies
Trial Treatment · Phase 1/2 · Princess Maxima Center for Pediatric Oncology
Schneider's Children's Medical Center, Petah Tikva · Sheba Medical Center Hospital, Ramat Gan
Registry updated 2025-09-16
NCT03643276
Treatment Protocol for Children and Adolescents With Acute Lymphoblastic Leukemia - AIEOP-BFM ALL 2017
Trial Treatment · Phase 3 · Martin Schrappe
Soroka University Medical Center, Beersheba · Rambam Health Care Campus, Haifa · Hadassah medical Center, Jerusalem · Schneider Children Medical Center of Israel, Petah Tikva · Sheba Medical Center, Tel Hashomer, Ramat Gan · Dana children hospital, Tel Aviv
Registry updated 2025-04-06

All Acute lymphoblastic leukaemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error